By contrast, several other investigations highlighted that high SPP1 levels were correlated with poor outcomes in many solid malignancies such as prostate cancer, lung cancer, gastric cancer and breast cancer [43,44,45,46]. The gene discussed is SPP1; the disease is prostate cancer.